Janus Kinase Inhibitors for Autoimmune Disorders

Prescriber - United Kingdom
doi 10.1002/psb.1635
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Wiley

Related search

Janus Kinase Inhibitors and Allogeneic Stem Cell Transplantation for Myelofibrosis

Biology of Blood and Marrow Transplantation
TransplantationHematology
2014English

Development of Selective Covalent Janus Kinase 3 Inhibitors

Journal of Medicinal Chemistry
Drug DiscoveryMolecular Medicine
2015English

Therapeutic Potential of Janus-Activated Kinase-2 Inhibitors for the Management of Myelofibrosis

Clinical Cancer Research
Cancer ResearchOncology
2010English

Role of Janus Kinase Inhibitors in the Treatment of Alopecia Areata

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2018English

Are Janus Kinase Inhibitors Superior Over Classic Biologic Agents in RA Patients?

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2018English

Systematic Review and Meta-Analysis: Efficacy and Safety of Oral Janus Kinase Inhibitors for Inflammatory Bowel Disease

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2019English

Tofacitinib: A Janus Kinase Inhibitor for Rheumatoid Arthritis

Prescriber
Pharmacology
2017English

Janus Kinase-3 (JAK-3)

Science-Business eXchange
2011English

Janus Kinase-2 (JAK-2)

Science-Business eXchange
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy